Your browser doesn't support javascript.
loading
Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.
DeVincenzo, John; Cass, Lindsey; Murray, Alison; Woodward, Kathy; Meals, Elizabeth; Coates, Matthew; Daly, Leah; Wheeler, Vicky; Mori, Julie; Brindley, Charlie; Davis, Amanda; McCurdy, Meabh; Ito, Kazuhiro; Murray, Bryan; Strong, Pete; Rapeport, Garth.
Affiliation
  • DeVincenzo J; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Cass L; Children's Foundation Research Institute, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
  • Murray A; Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Woodward K; Pulmocide Ltd, London, United Kingdom.
  • Meals E; Pulmocide Ltd, London, United Kingdom.
  • Coates M; Pulmocide Ltd, London, United Kingdom.
  • Daly L; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Wheeler V; Children's Foundation Research Institute, Le Bonheur Children's Hospital, Memphis, Tennessee, USA.
  • Mori J; Pulmocide Ltd, London, United Kingdom.
  • Brindley C; Pulmocide Ltd, London, United Kingdom.
  • Davis A; hVIVO Services Ltd, London, United Kingdom.
  • McCurdy M; hVIVO Services Ltd, London, United Kingdom.
  • Ito K; KinetAssist Ltd, Quothquan, United Kingdom.
  • Murray B; Pulmocide Ltd, London, United Kingdom.
  • Strong P; Exploristics Ltd, Belfast, United Kingdom.
  • Rapeport G; Pulmocide Ltd, London, United Kingdom.
J Infect Dis ; 225(12): 2087-2096, 2022 06 15.
Article in En | MEDLINE | ID: mdl-33216113

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Respiratory Syncytial Virus Infections Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Infect Dis Year: 2022 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Respiratory Syncytial Virus Infections Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Infect Dis Year: 2022 Document type: Article Affiliation country: Estados Unidos